Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalky

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – C-o-group doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31045

Patent

active

053527089

ABSTRACT:
The present invention provides cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives, substituted in the 1-position with halo, methyl, hydroxyl, nitro, amino, amido, azido, oxime, cyano, thiol, either or thioether groups, e.g., a 1-OH cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivatives. The cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) derivatives of the present invention are potent ocular hypotensives, and are particularly suitable for the management of glaucoma. Moreover, the cyclopentane heptanoic, 2-(cycloalkyl or arylalkyl) derivatives of this invention are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases; smooth muscle relaxants with application in gastrointestinal disease, reproduction, fertility, incontinence, shock, etc.

REFERENCES:
patent: 4055602 (1977-10-01), Nelson
patent: 4171331 (1979-10-01), Biddlecom et al.
patent: 4183870 (1980-01-01), Caton
patent: 4599353 (1986-07-01), Bito
patent: 4994274 (1991-02-01), Chan et al.
patent: 5034413 (1991-07-01), Chan et al.
Prostaglandins: vol. 13, No. 5, May 1977, Stoneham, Mass., pp. 837-843, H. C. Arndt, "The Synthesis and Biological Activity of Prostaglandins Analogs Containing Spiroocyclic Rings".
Tetrahedron: vol. 32, 1976, Oxford GB, pp. 2747-2752, P. DeClercq et al, "Cyclopentanones-XV1,. Prostaglandin Synthesis Involving Catalytic Hydrogenation of 2,3-Dialkyl-4-Hydroxy-2-Cyclopentenones".
Derwent Publications Ltd., London, GB; AN 71-57222S & JP,A,46 030 830 (Ono Pharmaceutical Co).
Bito, Laszlo Z., "Prostaglandins, Old Concepts and New Perspectives," Arch Ophth. vol. 105, Aug. 1987 pp. 1036-1039.
Siebold, et al., "Esterified prostaglandin shows `potent` promise", Prodrug 5,3, Feb. 1, 1989.
Starr, Michael S., "Further Studies on the Effect of Prostaglandin on Intraocular Pressure in the Rabbit," Exp. Eye Res., (1971) 170-177.
Nilsson, Siv F. E., et al., "PGF2a Increases Uveoscleral Outflow," ARVO Abstracts, p. 284 Invest. Ophthalmol. Vis.Sci. 28 (suppl) (1987).
Bito, Laszlo Z., "Prostaglandins, Other Eicosanoids, and Their Derivatives as Potential Antiglaucoma Agents," Applied Pharmacology in the Medical Treatment of Glaucomas Drance, S. M. and Neufeld, A. H. eds, New York, Grune & Stratton, 1984 pp. 477-505.
Bito, Laszlo Z., "Prostaglandins and Related Compounds as Potential Ocular Therapeutic Agents," Biological Protection with Prosataglandins (Cohen, M. M., ed., Boca Raton, Fla., CRC Press Inc., 1985, pp. 231-252.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalky does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalky, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalky will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-581614

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.